CA
CTVA icon

Cullinan Associates’s Corteva CTVA Stock Holding History

Cullinan Associates’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$445K Buy
5,733
+726
+14% +$60.1K 0.03% 167
2026
Q2 		$424K Sell
5,007
-1,060
-17% -$85.1K 0.03% 162
2026
Q1 		$508K Buy
6,067
+200
+3% +$15.1K 0.04% 156
2025
Q4 		$393K Sell
5,867
-100
-2% -$6.46K 0.03% 174
2025
Q3 		$404K Buy
5,967
+115
+2% +$8.33K 0.03% 175
2025
Q2 		$436K Sell
5,852
-377
-6% -$25.1K 0.03% 175
2025
Q1 		$392K Sell
6,229
-930
-13% -$57.5K 0.03% 180
2024
Q4 		$408K Sell
7,159
-10,600
-60% -$627K 0.03% 177
2024
Q3 		$1.05M Sell
17,759
-7,110
-29% -$388K 0.06% 136
2024
Q2 		$1.34M Sell
24,869
-3,380
-12% -$186K 0.08% 129
2024
Q1 		$1.63M Sell
28,249
-150,120
-84% -$7.75M 0.09% 128
2023
Q4 		$8.55M Sell
178,369
-18,564
-9% -$885K 0.48% 49
2023
Q3 		$10.1M Sell
196,933
-4,035
-2% -$214K 0.59% 42
2023
Q2 		$11.5M Sell
200,968
-19,560
-9% -$1.14M 0.63% 42
2023
Q1 		$13.3M Buy
220,528
+755
+0.3% +$46.1K 0.78% 35
2022
Q4 		$12.9M Sell
219,773
-4,955
-2% -$314K 0.72% 31
2022
Q3 		$12.8M Sell
224,728
-9,086
-4% -$530K 0.81% 33
2022
Q2 		$12.7M Buy
233,814
+1,205
+0.5% +$70K 0.77% 36
2022
Q1 		$13.4M Buy
232,609
+7,964
+4% +$407K 0.7% 42
2021
Q4 		$10.6M Buy
224,645
+19,747
+10% +$899K 0.54% 50
2021
Q3 		$8.62M Buy
204,898
+28,900
+16% +$1.25M 0.48% 59
2021
Q2 		$7.81M Buy
175,998
+54,591
+45% +$2.52M 0.44% 69
2021
Q1 		$5.66M Sell
121,407
-120,063
-50% -$5.31M 0.33% 85
2020
Q4 		$9.35M Sell
241,470
-6,661
-3% -$238K 0.56% 47
2020
Q3 		$7.15M Buy
248,131
+115,200
+87% +$3.24M 0.46% 53
2020
Q2 		$3.56M Buy
132,931
+19,067
+17% +$496K 0.25% 90
2020
Q1 		$2.68M Buy
113,864
+9,544
+9% +$262K 0.22% 92
2019
Q4 		$3.08M Buy
104,320
+22,425
+27% +$594K 0.21% 95
2019
Q3 		$2.29M Buy
81,895
+44,430
+119% +$1.28M 0.16% 107
2019
Q2 		$1.11M Buy
+37,465
New +$1.01M 0.08% 127

Other funds holding CTVA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Cullinan Associates's CTVA Position: Q3 2026 in Review

Cullinan Associates increased its Corteva (CTVA) stake by 14% in Q3 2026, buying an estimated $60.1K and bringing the position to 5,733 shares worth $445K. The position accounts for 0.03% of the portfolio, ranked #167.

Cullinan Associates first reported a position in CTVA in Q2 2019 and has held it in 30 quarters since. The position peaked at $13.4M in Q1 2022. 835 funds tracked by Wall St. Rank hold CTVA as of Q3 2026.

  • Cullinan Associates held 5,733 shares of Corteva worth $445K as of Q3 2026.
  • Cullinan Associates bought 726 Corteva shares in Q3 2026, an estimated $60.1K.
  • Corteva made up 0.03% of Cullinan Associates's portfolio in Q3 2026, its #167 holding.
  • Cullinan Associates first reported a position in Corteva in Q2 2019 and has held it in 30 quarters since.
  • Cullinan Associates's Corteva position peaked at $13.4M in Q1 2022.
  • 835 funds tracked by Wall St. Rank held Corteva as of Q3 2026.

Based on Cullinan Associates's 13F filing for Q3 2026, filed 3 Nov 2026.